What about the mother?
This refers to your article on concerns regarding the Prevention of Mother to Child Transmission (PMTCT) trials. NACO’s programme to prevent mother to child transmission of HIV, although ambitious, was awaited by obstetricians all over the country, particularly in the high prevalence states, for five-six years. Many institutes have evidence that seropositivity of HIV amongst women who come in for prenatal care is above 1%, sometimes as high as 4-7%.
There are currently no refbacks.